Novadip Biosciences
Pre-clinicalNovadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
Founded
2013
Focus
BiologicsCell & Gene Therapy
About
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
Funding History
3Total raised: $62.5M
Series B$40MFund+Sep 15, 2021
Series A$20MFund+Jun 15, 2018
Seed$2.5MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2013
LocationMont-Saint-Guibert, Belgium
StagePre-clinical
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile